The effect of the endothelin ET A receptor antagonist CI-1020 on hypoxic pulmonary vasoconstriction

By Jones R.D.   Wanstall J.C.   Gambino A.   Morice A.H.  

European Journal of Pharmacology, Vol. 374, Iss. 3, 1999-06 ,pp. : 367-375

Elsevier

Access to resources Recommend Favorite

Inhibition of Hypoxic Pulmonary Vasoconstriction in Isolated Rat Pulmonary Arteries by Diphenyleneiodonium (DPI)

By Thompson J.S.   Jones R.D.   Rogers T.K.   Hancock J.   Morice A.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 1, 1998-02 ,pp. : 71-75

Academic Press

Access to resources Recommend Favorite

The Effect of the ET_A Receptor Antagonist (CI-1020) in Rats with Established Hypoxic Pulmonary Hypertension

By Sheedy W.   Haleen S.   Morice A.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 173-176

Academic Press

Access to resources Recommend Favorite

Nuclear factor- B inhibitors abolish hypoxic vasoconstriction in sheep-isolated pulmonary arteries

By Uzun O.   Demiryurek A.T.  

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 171-174

Elsevier

Access to resources Recommend Favorite

Effects of the endothelin ET A receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats

By Itoh H.   Yokochi A.   Yamauchi-Kohno R.   Maruyama K.  

European Journal of Pharmacology, Vol. 376, Iss. 3, 1999-07 ,pp. : 233-238

Elsevier

Access to resources Recommend Favorite